Royal Bank Of Canada Immunocore Holdings PLC Transaction History
Royal Bank Of Canada
- $479 Billion
- Q4 2024
A detailed history of Royal Bank Of Canada transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Royal Bank Of Canada holds 30,322 shares of IMCR stock, worth $910,872. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30,322
Previous 44,970
32.57%
Holding current value
$910,872
Previous $1.4 Million
36.1%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding IMCR
# of Institutions
125Shares Held
42.5MCall Options Held
79.9KPut Options Held
46.2K-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.7MShares$201 Million0.12% of portfolio
-
Wellington Management Group LLP Boston, MA6.62MShares$199 Million0.04% of portfolio
-
Rtw Investments, LP New York, NY4.87MShares$146 Million2.34% of portfolio
-
Primecap Management CO Pasadena, CA2.67MShares$80.2 Million0.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.19MShares$65.7 Million0.01% of portfolio
About Immunocore Holdings plc
- Ticker IMCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,897,100
- Market Cap $1.32B
- Description
- Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...